Proinflammatory interleukins, such as interleukin-1β (IL-1β) and interleukin-18 (IL-18), play a significant role in cancer progression by modulating the tumor microenvironment and influencing various stages of tumor development. This evidence concerns the gene IL18 and neoplasm.